For the Inventor, By the Inventor

Enter assignee name

Sun Pharma Advanced Research Company Limited

Calculating rank

USPTO Granted Patents = 66

% Expired Patents = 25.8

CIPO Patents = 4

EPO Patents = 23

Trademarks = 29

Forward Citations = 303

Loading Chart...

Loading Chart...

111 inventors (with patents filed for the assignee):

Yashoraj Rupsinh Zala (21 out of 22 patents)

Nitin Bhalachandra Dharmadhikari (20 out of 26 patents)

Ajay Khopade (18 out of 18 patents)

4. Arindam Halder (13 out of 13 patents)

5. Trinadha Rao Chitturi (11 out of 18 patents)

6. Subhas Balaram Bhowmick (8 out of 45 patents)

7. Rajamannar Thennati (8 out of 47 patents)

8. Prabal Sengupta (6 out of 6 patents)

9. Jayraj Dilipbhai Aradhye (5 out of 5 patents)

10. Bhavesh Mohanbhai Panchal (5 out of 5 patents)

11. Gaurav Sanjivkumar Sheth (5 out of 5 patents)

12. Satish Madhukar Gokhale (5 out of 5 patents)

13. Abhijit Takale (4 out of 26 patents)

14. Bramhanand Hanamannavar (4 out of 4 patents)

15. Prashant Kane (4 out of 35 patents)

Core Competencies:

Ophthalmic Solutions

Bioavailability Enhancement

Drug Delivery Systems

Multiparticulate Compositions

Prostaglandin Compositions

Abuse Deterrent Formulations

Nanodispersion

Parkinson's Disease Treatment

Heterocyclic Antiestrogens

Controlled Release Tablets

Cysteinyl Leukotriene Antagonists

Inhalation Devices

66 patents: Sort by Forward Citations

1. 12636254 - Stabilization of phenobarbital sodium for injection (2026-05-26),

2. 12527792 - Stable multiparticulate pharmaceutical composition of rosuvastatin (2026-01-20),

3. 12409175 - Method of increasing bioavailability and/or prolonging ophthalmic action of a drug (2025-09-09),

4. 12383496 - Ophthalmic solution of difluprednate (2025-08-12),

5. 12194153 - Amorphous dispersion of 4-methyl-3-quinolin-3-ylethynyl-benzoic acid n'-(2-chloro-6-methyl-benzoyl) hydrazide (2025-01-14),

6. 11951106 - Method of increasing bioavailability and/or prolonging ophthalmic action of a drug (2024-04-09),

7. 11931359 - Method of increasing bioavailability and/or prolonging ophthalmic action of a drug (2024-03-19),

8. 11890375 - Ophthalmic solution of difluprednate (2024-02-06),

9. 11857683 - Stabilization of phenobarbital sodium for injection (2024-01-02),

10. 11813252 - Treatment for Parkinson's disease (2023-11-14),

11. 11583522 - Treatment for Parkinson's disease (2023-02-21),

12. 11559487 - Drug loaded nanoresin particles (2023-01-24),

13. 11465990 - Heterocyclic antiestrogens (2022-10-11),

14. 11439600 - Abuse deterrent oral solid dosage form (2022-09-13),

15. 11351123 - Amorphous dispersion of 4-methyl-3-quinolin-3-ylethynyl-benzoic acid n'-(2-chloro-6-methyl-benzoyl) hydrazide (2022-06-07),

Company Overview

Sun Pharma Advanced Research Company Limited, based in Mumbai, specializes in the development of innovative ophthalmic formulations. The company focuses on enhancing bioavailability and optimizing drug delivery systems, particularly through multiparticulate compositions and prostaglandin formulations. Additionally, it explores advanced technologies such as abuse deterrent formulations and nanodispersion techniques. Its research extends to addressing complex medical conditions, including treatments for Parkinson's disease, positioning it as a key player in the pharmaceutical landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

66 Patents

#8 in Mumbai

#29 in India

#11,184 in the World

Sun Pharma Advanced Research Company Limited

Forward Citations = 303

111 inventors:

Yashoraj Rupsinh Zala (21 out of 22 patents)

Nitin Bhalachandra Dharmadhikari (20 out of 26 patents)

Ajay Khopade (18 out of 18 patents)

4. Arindam Halder (13 out of 13 patents)

5. Trinadha Rao Chitturi (11 out of 18 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sun Pharma Advanced Research Company Limited. Retrieved from https://idiyas.com/company/sun-pharma-advanced-research-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…